Leukemia, Myelodysplasia, Transplantation

From the Journals

Targeted CLL treatments found effective in managing associated autoimmune cytopenias

Author:

Andrew D. Bowser

Preexisting autoimmune cytopenias frequently improved or resolved on ibrutinib, idelalisib, or venetoclax, while...

• Read More

Conference Recap

Leukemia highlights from ASCO 2021

Author:

Michael R. Grunwald, MD

• Read More

Conference Coverage

Ponatinib/blinatumomab start strong against Ph+ALL

Author:

Neil Osterweil

The combined agents were associated with high complete response and molecular remission rates as frontline...

• Read More

Conference Coverage

HMAs benefit children with relapsed/refractory AML

Author:

Neil Osterweil

Azacitidine and decitabine alone or in combination may help children and young adults reach stem cell transplant...

• Read More

Conference Coverage

Reduced-intensity transplant benefits older patients with AML

Author:

Nancy A. Melville

This improvement in survival is seen regardless of key factors such as genotype and the status of minimal...

• Read More

Conference Coverage

CAR T cells rescue younger children with relapsed/refractory ALL

Author:

Neil Osterweil

Children younger than 3 years with relapsed/refractory acute lymphoblastic leukemia had CAR T therapy outcomes similar to those of older children...

• Read More

Conference Coverage

GLOW: Ibrutinib+venetoclax shines in first line for CLL/SLL

Author:

Neil Osterweil

Fixed-duration therapy with the combo was associated with high progression-free survival and undetectable...

• Read More

Conference Coverage

Venetoclax shows activity against T-ALL in children

Author:

Neil Osterweil

Patients with T-lineage acute lymphoblastic leukemia (4/7) in a small retrospective study had complete responses...

• Read More

Conference Coverage

Sex differences in pediatric B-ALL outcomes persist

Author:

Neil Osterweil

Boys with B-lineage acute lymphoblastic leukemia continue to have slightly worse survival outcomes than girls...

• Read More

Conference Coverage

Pediatric cancer survivors at risk for opioid misuse

Author:

Neil Osterweil

In the first year after the end of treatment, survivors of childhood cancers were at significantly greater risk...

• Read More

Conference Coverage

High MRD rates with CAR T in r/r B-ALL in kids

Author:

Neil Osterweil

Of 24 patients with relapsed/refractory disease, 16 went on to allogeneic stem cell transplant after responding to therapy with KTE-X19.

• Read More